MCK · 8-K · 20260805PR000232

Specialty Distribution Growth

MCKESSON CORP · 2026-08-05 · Importance 64 · Surprise 56

The North American Pharmaceutical segment reported $86.8 billion of revenue, up 5% year over year, driven by increased prescription transaction volumes and higher specialty-product volumes. Growth in specialty distribution to health systems and strategic accounts contributed to segment operating performance. Oncology & Multispecialty revenue increased 33% to $14.2 billion, with growth in provider solutions and specialty distribution. The segment’s growth included contributions from acquisitions, although the release provides no further product or customer-level detail.

Key facts

• Oncology & Multispecialty Segment Operating Profit: $325 million; Adjusted Segment Operating Profit: $405 million, an increase of 41%. source